Velarion Records
Free. Unsubscribe any time.

Centessa Pharmaceuticals plc (CNTA)

Centessa Pharmaceuticals plc filed 47 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 7 reporting owners, covering 62 transactions and 1,305,829 shares. None carries the SEC's AFF10B5ONE flag; all 47 name a plan in a footnote. 4 results prints are on file in the same window.

What stands out

Trades in Centessa Pharmaceuticals plc 62

Adoption dates in Centessa Pharmaceuticals plc 7

Results prints in Centessa Pharmaceuticals plc 4

Trades before a print in Centessa Pharmaceuticals plc 1

Interval to Centessa Pharmaceuticals plc’s next reported results date

How the interval and sources are counted →

Adoption dates Centessa Pharmaceuticals plc states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on February 14, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.